United Advisor Group’s AbbVie ABBV Stock Holding History

United Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.55M	Buy	5,913 +222	+4%	+$56.9K	0.15%	164
2026 Q2	$1.43M	Sell	5,691 -59	-1%	-$12.7K	0.15%	160
2026 Q1	$1.25M	Buy	5,750 +53	+0.9%	+$11.8K	0.15%	160
2025 Q4	$1.3M	Buy	5,697 +272	+5%	+$62K	0.16%	151
2025 Q3	$1.26M	Buy	5,425 +2,317	+75%	+$472K	0.17%	140
2025 Q2	$577K	Buy	3,108 +190	+7%	+$35.3K	0.1%	200
2025 Q1	$611K	Sell	2,918 -1,554	-35%	-$302K	0.13%	164
2024 Q4	$795K	Buy	4,472 +90	+2%	+$16.5K	0.16%	149
2024 Q3	$865K	Buy	4,382 +2,075	+90%	+$387K	0.2%	118
2024 Q2	$396K	Buy	+2,307	New	+$382K	0.12%	166

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

United Advisor Group's ABBV Position: Q3 2026 in Review

United Advisor Group increased its AbbVie (ABBV) stake by 3.9% in Q3 2026, buying an estimated $56.9K and bringing the position to 5,913 shares worth $1.55M. The position accounts for 0.15% of the portfolio, ranked #164.

United Advisor Group first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

United Advisor Group held 5,913 shares of AbbVie worth $1.55M as of Q3 2026.
United Advisor Group bought 222 AbbVie shares in Q3 2026, an estimated $56.9K.
AbbVie made up 0.15% of United Advisor Group's portfolio in Q3 2026, its #164 holding.
United Advisor Group first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on United Advisor Group's 13F filing for Q3 2026, filed 3 Nov 2026.